Treatment of mice infected with methicillin-resistant Staphylococcus aureus.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D008297:Male; D008712:Methicillin / Q000494:pharmacology*; D051379:Mice; D010403:Penicillin Resistance; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D014295:Trimethoprim; D013420:Sulfamethoxazole; D008712:Methicillin; D012293:Rifampin